GSK3B and hepatocellular carcinoma: β-catenin-370aa competitively binds to GSK3β to prevent the binding and phosphorylation of GSK3β and β-catenin, thereby antagonizing the GSK3β-induced degradation of β-catenin and activating the Wnt pathway to promote the growth and metastasis of HCC cells (91).